Real-world cell-free circulating tumor DNA (ctDNA) analysis identifies CDK4/6 inhibitor resistance and tumor evolution in HR+ advanced breast cancer. - Wander SA; Weipert CM; Cabel L; Liao J; Zhang N; Safonov A; Bardia A; Razavi P (NPJ breast cancer, 2026)